Tumores neuroendocrinos gastrointestinales pdf

World J Surg. Surgical strategy for large or malignant endocrine pancreatic tumors. Treatment of primary endocrine tumors. J Chir Paris. Liver metasta- translacional. Eur J Gastroenterol Hepatol. Aggressive surgery for metastatic liver neuroendocrine tumors. Treatment of hepatic metastases 1. The diagnosis and medical ma- from gastroenteropancreatic neuroendocrine tumors: role of liver trans- nagement of advanced neuroendocrine tumors.

Endocr Rev. Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, 2. N Engl J Med. WW, et al. Guidelines for the diagnosis and treatment of neuroendocrine Proye C.

Natural history of liver metastasis of gastroenteropancreatic gastrointestinal tumours. A consensus statement on behalf of the Euro- neuroendocrine tumors: place for chemoembolization.

Interferon-alpha 2b, with or without prior hepatic artery emboliza- Consensus report on the use of somatostatin analogs for the manage- tion: clinical response and survival in mid-gut carcinoid patients.

The ment of neuroendocrine tumors of the gastroenteropancreatic system. Norwegian carcinoid study. Scand J Gastroenterol. Houghton, G. Watson, D. Carcinoid disease. Review of the literature.

Dis Colon Rectum, 40 , pp. Absence of overexpression of p53 protein by intestinal carcinoid tumors. Higham, L. Bishop, R. Dimaline, C. Blackmore, A.

Dobbins, A. Varro, et al. Mutations of Regalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology, 16 , pp.

Debelenko, M. Emmert-Buck, Z. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Lehy, M. Mignon, G. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.

Gastroenterology, 96 , pp. Lehy, G. Mignon, P. Ruszniewski, S. Influence of multiple endocrine cells in patients with Zollinger-Ellison syndrome. Gut, 33 , pp. Jakobovitz, D. Nass, L. Carcinoid tumors frequently display genetic abnormalities involving chromosome J Clin Endocrinol Metab, 81 , pp. Debelenko, E. Brambilla, S. Identification of MEN-1 gene mutation in sporadic carcinoid tumors of the lung. Hum Mol Genet, 6 , pp. Ullmann, A. Schwendel, G. Klementt Wolf, I.

Petersen, H. Umbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridation.

Hum Pathol, 29 , pp. Keller, C. Bordi, H. Loss of heterozygosidad in 11q regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest, 79 , pp. Petzmann, R. Ullmann, J.

Halbwedl, H. Analysis of chromosome 11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridation-based study.

Virchows Arch, , pp. Zhao, R. Meier, E. Speel, P. Saremasiani, S. Muletta-Feurer, et al. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors carcinoids marked differences indicating diversity in molecular pathogenesis. Am J Pathol, , pp. Tonnies, M. Toliat, C. Analysis of sporadic neuroendocrine tumors of the enteropancreatic system by comparative genomic hybridation.

Gut, 48 , pp. Lollgen, O. Hessman, E. Chromosome 18 deletions are comon events in classical midgut carcinoid tumors. Int J Cancer, 92 , pp. Kytola, A. Hoog, B. Comparotive genomic hybridation identifies loss of 18qqter as an early and specific event in tumorigenesis of midgut carcinoids. Wang, C. Johnston, K. Oncogene expresion in gastroenteropancreatic neuroendocrine tumors. Descargar ahora. Carrusel anterior Carrusel siguiente. Buscar dentro del documento. Referencias 1. Gastroenterology ; 2.

Lancet Oncol ; 3. Cancer ; 4. Cancer ; 5. Br J Cancer ; 6. Guidelines for the management of gastroenteropancreatic neuroendocrine including carcinoid tumours.

Gut ; 54 Suppl 4: iv1-i16 7. Rehfeld JF. The new biology of gastrointestinal hormones. Physiol Rev ; 8. Best Pract Res Clin Gastroenterol ; 9. Am J Gastroenterol ; Williams ED, Sandler M. The classification of carcinoid tum ours. Lancet ; 1: TNM staging of midgut and hindgut neuro endocrine tumors: a consensus proposal including a grading system.

Dis Colon Rectum ; Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.

Prospective study of gastrin provocative testing in patients from the National Institutes of Health and comparison with cases from the literature. Medicine Baltimore ; Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas.

Ann Surg ; ; discussion Consensus guidelines for the management of patients with liver metastases from digestive neuro endocrine tumors: foregut, midgut, hindgut, and unknown primary. A follow-up study of patients with Zollinger- Ellison syndrome in the period effects of surgical and medical treatments on long-term survival. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.

Grant CS. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Am J Gastroenterol ; ; quiz IDrugs ; Combination therapy with octreotide and alphainterferon:effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumors and carcinoid syndrome.

The doxorubicinstreptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet- cell carcinoma.

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Hematol Oncol Clin North Am ; ; x Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res ; Phase II study of the proteasome inhibitor bortezomib PS in patients with metastatic neuroendocrine tumors. Indiumpentetreotide prolongs survival in gastroenteropancreatic malignancies. Alex Rafael. Adha Santo's. Arelis Jumbo. Erinson Custodio Plasencia. Marian Bufaico Lopez.

Fran Acuarela. Joshua Wright. Imagen correspondiente al caso 1 en la que se observa ul- sin mejora del cuadro. Con estos resultados se confir- ingesta a las 0. Fi- to de los valores. Tras la hipoglucemia, glucosa, 28 nicos,7,8. Ante la sospecha de in- identificar el insulinoma.

B Endocrinol Nutr. Sin embargo, estas dos exploraciones los resultados existentes son contradictorios En am- Endocrinol Nutr. Curr Opin Endocrinol Diabe- los resultados de las determinaciones hormonales.

En tes. Gastrointest Endosc. Service FJ. Endocrinol Metab Clin North Am.